KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Retained Earnings (2016 - 2025)

Sarepta Therapeutics has reported Retained Earnings over the past 16 years, most recently at $272000.0 for Q4 2025.

  • For Q4 2025, Retained Earnings rose 224.77% year-over-year to $272000.0; the TTM value through Dec 2025 reached $272000.0, up 224.77%, while the annual FY2025 figure was $272000.0, 224.77% up from the prior year.
  • Retained Earnings for Q4 2025 was $272000.0 at Sarepta Therapeutics, up from $220000.0 in the prior quarter.
  • Over five years, Retained Earnings peaked at $2.2 million in Q3 2024 and troughed at -$4.7 billion in Q1 2025.
  • A 5-year average of -$1.2 billion and a median of -$318500.0 in 2023 define the central range for Retained Earnings.
  • Biggest five-year swings in Retained Earnings: plummeted 177162800.0% in 2022 and later surged 451.88% in 2024.
  • Year by year, Retained Earnings stood at -$20000.0 in 2021, then tumbled by 8220.0% to -$1.7 million in 2022, then skyrocketed by 155.17% to $918000.0 in 2023, then tumbled by 123.75% to -$218000.0 in 2024, then surged by 224.77% to $272000.0 in 2025.
  • Business Quant data shows Retained Earnings for SRPT at $272000.0 in Q4 2025, $220000.0 in Q3 2025, and -$51000.0 in Q2 2025.